HomeASBP • NASDAQ
add
Aspire Biopharma Holdings Inc
Previous close
$0.23
Day range
$0.23 - $0.25
Year range
$0.22 - $15.80
Market cap
12.27M USD
Avg Volume
398.04K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 640.51K | 739.43% |
Net income | -738.50K | -861.79% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.63K | -67.49% |
Total assets | 147.99K | 220.50% |
Total liabilities | 1.69M | 216.10% |
Total equity | -1.54M | — |
Shares outstanding | 440.00M | — |
Price to book | ∞ | — |
Return on assets | -964.54% | — |
Return on capital | 1,444.35% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -738.50K | -861.79% |
Cash from operations | 479.57K | 80.70% |
Cash from investing | — | — |
Cash from financing | -492.48K | -83.20% |
Net change in cash | -12.91K | -277.10% |
Free cash flow | -149.69K | — |
About
Founded
2021
Website
